Anzahl der Einträge: 19.
Artikel
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Schaub, Christina,
Potthoff, Anna-Laura,
Steinbach, Joachim P.,
Schlegel, Uwe,
Sabel, Michael ![ORCID 0009-0000-1485-7820](/images/orcid_16x16.gif)
,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Pietsch, Torsten,
Tzaridis, Theophilos,
Zeyen, Thomas,
Borger, Valeri,
Güresir, Erdem,
Vatter, Hartmut,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
Journal of Neuro-Oncology 159 (1), S. 95-101.
Zeyen, Thomas,
Potthoff, Anna-Laura,
Nemeth, Robert,
Heiland, Dieter H.,
Burger, Michael C.,
Steinbach, Joachim P.,
Hau, Peter,
Tabatabai, Ghazaleh,
Glas, Martin,
Schlegel, Uwe,
Grauer, Oliver,
Krex, Dietmar,
Schnell, Oliver,
Goldbrunner, Roland,
Sabel, Michael ![ORCID 0009-0000-1485-7820](/images/orcid_16x16.gif)
,
Thon, Niklas,
Delev, Daniel,
Clusmann, Hans,
Seidel, Clemens,
Güresir, Erdem,
Schmid, Matthias ![ORCID 0000-0002-0788-0317](/images/orcid_16x16.gif)
,
Schuss, Patrick ![ORCID 0000-0002-5806-2576](/images/orcid_16x16.gif)
,
Giordano, Frank A.,
Radbruch, Alexander,
Becker, Albert,
Weller, Johannes,
Schaub, Christina,
Vatter, Hartmut,
Schilling, Judith,
Winkler, Frank ![ORCID 0000-0003-4892-6104](/images/orcid_16x16.gif)
,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
Trials 23 (1).
Volltext nicht vorhanden.
Schäfer, Niklas,
Bumes, Elisabeth ![ORCID 0000-0001-6915-3206](/images/orcid_16x16.gif)
,
Eberle, Fabian ![ORCID 0000-0002-1473-6065](/images/orcid_16x16.gif)
,
Fox, Viola,
Gessler, Florian,
Giordano, Frank A.,
Konczalla, Juergen,
Onken, Julia,
Ottenhausen, Malte,
Scherer, Moritz,
Schneider, Matthias,
Vatter, Hartmut,
Herrlinger, Ulrich und
Schuss, Patrick ![ORCID 0000-0002-5806-2576](/images/orcid_16x16.gif)
(2021)
Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.
Journal of Neuro-Oncology 153 (3), S. 479-485.
Tzaridis, Theophilos ![ORCID 0000-0001-9651-1144](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Weller, Johannes,
Steinbach, Joachim‐Peter,
Schlegel, Uwe,
Seidel, Sabine,
Sabel, Michael,
Hau, Peter,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Tonn, Jörg‐Christian,
Grauer, Oliver,
Kebir, Sied,
Schneider, Matthias,
Schaub, Christina,
Vatter, Hartmut,
Coch, Christoph,
Glas, Martin,
Fimmers, Rolf,
Pietsch, Torsten,
Reifenberger, Guido,
Herrlinger, Ulrich und
Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), S. 1695-1707.
Volltext nicht vorhanden.
van den Bent, Martin J.,
Tesileanu, C. Mircea S. ![ORCID 0000-0003-3541-9242](/images/orcid_16x16.gif)
,
Wick, Wolfgang,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Erridge, Sarah,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Baurain, Jean Français,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Rogers, Leland,
Taal, Walter ![ORCID 0000-0002-5530-7259](/images/orcid_16x16.gif)
,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Caparrotti, Francesca,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Lim, Elizabeth,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
de Heer, Iris,
Aldape, Kenneth,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Kros, Johan M.,
Wesseling, Pieter,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
French, Pim und
Baumert, Brigitta G.
(2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
The Lancet Oncology 22 (6), S. 813-823.
Volltext nicht vorhanden.
Hau, Peter,
Dirven, Linda,
Luerding, Ralf,
Beier, Dagmar,
Bumes, Elisabeth,
Reinert, Christiane,
Seidel, Clemens,
Bonsanto, Matteo Mario,
Bremer, Michael,
Rieken, Stefan,
Combs, Stephanie E.,
Herrlinger, Ulrich,
Seliger, Corinna,
Kuntze, Holger,
Mayer‑Steinacker, Regine,
Dieing, Annette,
Bartels, Claudius,
Schnell, Oliver,
Weyerbrock, Astrid,
Seidel, Sabine,
Grauer, Oliver,
Nadji‑Ohl, Minou,
Paulsen, Frank ![ORCID 0000-0002-1748-174X](/images/orcid_16x16.gif)
,
Weller, Michael und
Wick, Wolfgang
(2020)
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
Journal of Neuro-Oncology 148, S. 117-130.
Kebir, Sied,
Schaub, Christina,
Junold, Nina,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Steinbach, Joachim P.,
Weyerbrock, Astrid,
Hau, Peter,
Goldbrunner, Roland,
Galldiks, Norbert ![ORCID 0000-0002-2485-1796](/images/orcid_16x16.gif)
,
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Mack, Frederic,
Tzaridis, Theophilos,
Bähr, Oliver,
Seidel, Clemens,
Schlegel, Uwe,
Schmidt-Graf, Friederike,
Rohde, Veit,
Borchers, Christian,
Tabatabai, Ghazaleh ![ORCID 0000-0002-3542-8782](/images/orcid_16x16.gif)
,
Hänel, Mathias,
Sabel, Michael,
Gerlach, Rüdiger,
Krex, Dietmar,
Belka, Claus,
Vatter, Hartmut,
Proescholdt, Martin,
Glas, Martin und
Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), S. 501-509.
Volltext nicht vorhanden.
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Hau, Peter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ![ORCID 0000-0002-3542-8782](/images/orcid_16x16.gif)
,
Brehmer, Stefanie,
Bullinger, Lars,
Galldiks, Norbert ![ORCID 0000-0002-2485-1796](/images/orcid_16x16.gif)
,
Schaub, Christina,
Kebir, Sied,
Stummer, Walter,
Simon, Matthias,
Fimmers, Rolf,
Coch, Christoph,
Glas, Martin,
Herrlinger, Ulrich und
Schäfer, Niklas
(2019)
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
The Lancet Oncology 20 (10), S. 1444-1453.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Sabel, Michael,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Kortmann, Rolf-Dieter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Schnell, Oliver,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ![ORCID 0000-0002-3542-8782](/images/orcid_16x16.gif)
,
Kowalski, Thomas,
Ringel, Florian,
Schmidt-Graf, Friederike,
Suchorska, Bogdana,
Brehmer, Stefanie,
Weyerbrock, Astrid,
Renovanz, Miriam,
Bullinger, Lars,
Galldiks, Norbert ![ORCID 0000-0002-2485-1796](/images/orcid_16x16.gif)
,
Vajkoczy, Peter,
Misch, Martin,
Vatter, Hartmut,
Stuplich, Moritz,
Schäfer, Niklas,
Kebir, Sied,
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Schaub, Christina,
Stummer, Walter,
Tonn, Jörg-Christian,
Simon, Matthias,
Keil, Vera C.,
Nelles, Michael,
Urbach, Horst,
Coenen, Martin,
Wick, Wolfgang ![ORCID 0000-0002-6171-634X](/images/orcid_16x16.gif)
,
Weller, Michael ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Fimmers, Rolf,
Schmid, Matthias ![ORCID 0000-0002-0788-0317](/images/orcid_16x16.gif)
,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Pietsch, Torsten,
Coch, Christoph und
Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
Schaub, Christina,
Kebir, Sied,
Junold, Nina,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Steinbach, Joachim P.,
Weyerbrock, Astrid,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Goldbrunner, Roland,
Niessen, Michael,
Mack, Frederic,
Stuplich, Moritz,
Tzaridis, Theophilos,
Bähr, Oliver,
Kortmann, Rolf-Dieter,
Schlegel, Uwe,
Schmidt-Graf, Friederike,
Rohde, Veit,
Braun, Christian,
Hänel, Mathias,
Sabel, Michael,
Gerlach, Rüdiger,
Krex, Dietmar,
Belka, Claus,
Vatter, Hartmut,
Proescholdt, Martin,
Herrlinger, Ulrich und
Glas, Martin
(2018)
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589.
Volltext nicht vorhanden.
van den Bent, Martin J.,
Baumert, Brigitta,
Erridge, Sara C.,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Baurain, Jean Francais,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Brachman, David G.,
Taal, Walter,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Weber, Damien C.,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Pascoe, Sarah,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
van Heuvel, Irene,
Stupp, Roger,
Aldape, Ken,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Dinjens, Winand N. M.,
Wesseling, Pieter ![ORCID 0000-0001-5453-5201](/images/orcid_16x16.gif)
,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
Wick, Wolfgang und
Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
Beier, Dagmar,
Proescholdt, Martin,
Reinert, Christiane,
Pietsch, Torsten,
Jones, David T. W. ![ORCID 0000-0002-2036-5141](/images/orcid_16x16.gif)
,
Pfister, Stefan M. ![ORCID 0000-0002-5447-5322](/images/orcid_16x16.gif)
,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Seidel, Clemens,
Dirven, Linda,
Luerding, Ralf,
Reijneveld, Jaap,
Warmuth-Metz, Monika,
Bonsanto, Matteo,
Bremer, Michael,
Combs, Stephanie E.,
Rieken, Stefan,
Herrlinger, Ulrich,
Kuntze, Holger,
Mayer-Steinacker, Regine,
Moskopp, Dag,
Schneider, Thomas,
Beringer, Andreas,
Schlegel, Uwe,
Stummer, Walter,
Welker, Helmut,
Weyerbrock, Astrid,
Paulsen, Frank,
Rutkowski, Stefan,
Weller, Michael,
Wick, Wolfgang,
Kortmann, Rolf-Dieter,
Bogdahn, Ulrich und
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
Schäfer, Niklas,
Proescholdt, Martin,
Steinbach, Joachim P,
Weyerbrock, Astrid,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Grauer, Oliver,
Goldbrunner, Roland,
Friedrich, Franziska,
Rohde, Veit,
Ringel, Florian,
Schlegel, Uwe,
Sabel, Michael,
Ronellenfitsch, Michael W,
Uhl, Martin,
Grau, Stefan,
Hänel, Mathias,
Schnell, Oliver,
Krex, Dietmar,
Vajkoczy, Peter,
Tabatabai, Ghazaleh,
Mack, Frederic,
Schaub, Christina,
Tzaridis, Theophilos,
Nießen, Michael,
Kebir, Sied,
Leutgeb, Barbara,
Urbach, Horst,
Belka, Claus,
Stummer, Walter,
Glas, Martin und
Herrlinger, Ulrich
(2017)
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Neuro-Oncology 20 (7), S. 975-985.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Schäfer, Niklas,
Steinbach, Joachim P. ![ORCID 0000-0002-1708-6440](/images/orcid_16x16.gif)
,
Weyerbrock, Astrid,
Hau, Peter,
Goldbrunner, Roland,
Friedrich, Franziska,
Rohde, Veit,
Ringel, Florian,
Schlegel, Uwe,
Sabel, Michael,
Ronellenfitsch, Michael W. ![ORCID 0000-0002-1402-6290](/images/orcid_16x16.gif)
,
Uhl, Martin,
Maciaczyk, Jaroslaw,
Grau, Stefan,
Schnell, Oliver,
Hänel, Mathias,
Krex, Dietmar,
Vajkoczy, Peter,
Gerlach, Rüdiger,
Kortmann, Rolf-Dieter,
Mehdorn, Maximilian,
Tüttenberg, Jochen,
Mayer-Steinacker, Regine,
Fietkau, Rainer,
Brehmer, Stefanie,
Mack, Frederic,
Stuplich, Moritz,
Kebir, Sied,
Kohnen, Ralf,
Dunkl, Elmar,
Leutgeb, Barbara,
Proescholdt, Martin,
Pietsch, Torsten,
Urbach, Horst,
Belka, Claus,
Stummer, Walter und
Glas, Martin
(2016)
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
Journal of Clinical Oncology 34 (14), S. 1611-1619.
Volltext nicht vorhanden.
Suchorska, Bogdana,
Weller, Michael,
Tabatabai, Ghazaleh,
Senft, Christian ![ORCID 0000-0003-1288-6913](/images/orcid_16x16.gif)
,
Hau, Peter,
Sabel, Michael C.,
Herrlinger, Ulrich,
Ketter, Ralf,
Schlegel, Uwe,
Marosi, Christine,
Reifenberger, Guido,
Wick, Wolfgang,
Tonn, Jörg C. und
Wirsching, Hans-Georg
(2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial.
Neuro-Oncology 18 (4), S. 549-556.
Volltext nicht vorhanden.
Hutterer, Markus,
Nowosielski, Martha,
Haybaeck, Johannes,
Embacher, Sabine,
Stockhammer, Florian,
Gotwald, Thaddäus,
Holzner, Bernhard,
Capper, David,
Preusser, Matthias,
Marosi, Christine,
Oberndorfer, Stefan,
Moik, Martin,
Buchroithner, Johanna,
Seiz, Marcel,
Tuettenberg, Jochen,
Herrlinger, Ulrich,
Wick, Antje,
Vajkoczy, Peter und
Stockhammer, Günther
(2014)
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro-Oncology 16 (1), S. 92-102.
Volltext nicht vorhanden.
Glas, Martin,
Hennemann, Burkhard,
Hirschmann, Birgit,
Marienhagen, Jörg,
Schmidt-Wolf, Ingo,
Herrlinger, Ulrich,
Bogdahn, Ulrich und
Hau, Peter
(2008)
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Acta oncologica 47 (3), S. 479-480.
Volltext nicht vorhanden.
Glas, Martin,
Koch, Horst,
Hirschmann, Birgit,
Jauch, Tanja,
Steinbrecher, Andreas,
Herrlinger, Ulrich,
Bogdahn, Ulrich und
Hau, Peter
(2007)
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.
Oncology 72 (5-6), S. 302-307.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Steinbrecher, A.,
Rieger, J.,
Hau, Peter,
Kortmann, R.-D.,
Meyermann, R.,
Schabet, M.,
Bamberg, M.,
Dichgans, J.,
Bogdahn, U. und
Weller, M.
(2005)
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Journal of neurology 252 (3), S. 291-299.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Sat Aug 17 02:08:58 2024 CEST.